Description
Fibron 40 mg contains febuxostat 40 mg, which selectively inhibits xanthine oxidase, an enzyme involved in the production of uric acid. By reducing uric acid production, febuxostat helps lower and maintain serum urate levels.
It is used in adults for chronic hyperuricaemia associated with gout, including patients with a history or presence of tophi or gouty arthritis. Febuxostat is a long-term urate-lowering treatment and does not provide immediate treatment for an acute gout flare.
















